Author

Rajesh R Wakaskar

Insys Therapeutics, Inc. - Cited by 608

Biography

Rajesh R Wakaskar is affiliated to Formulation Scientist, Insys Therapeutics, USA. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals.   
Title
Cited by
Year
General overview of lipid–polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes
RR WakaskarJournal of drug targeting 26 (4), 311-318, 2018201
140
2018
Passive and Active Targeting in Tumor Microenvironment
RR WakaskarInternational Journal of Drug Development and Research 9 (2), 37-41, 2017201
73
2017
Sildenafil sublingual spray formulations
T Potta, K Amancha, W Giron, N Yan, V Goskonda, ON Singh, H Redman, ...US Patent 10,111,833, 201869201
69
2018
Promising effects of nanomedicine in cancer drug delivery
RR WakaskarJournal of drug targeting 26 (4), 319-324, 2018201
64
2018
Polymeric micelles and their properties
RR WakaskarJ. Nanomed. Nanotechnol 8 (2), 10.72, 2017201
41
2017
Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean …
RR Wakaskar, SPR Bathena, SB Tallapaka, VV Ambardekar, N Gautam, ...Pharmaceutical research 32, 1028-1044, 2015201
37
2015
The efficacy of nuclease-resistant Chol-siRNA in primary breast tumors following complexation with PLL-PEG (5K)
VV Ambardekar, RR Wakaskar, B Sharma, J Bowman, W Vayaboury, ...Biomaterials 34 (20), 4839-4848, 2013201
33
2013
Brief overview of nanoparticulate therapy in cancer
RR WakaskarJournal of drug targeting 26 (2), 123-126, 2018201
29
2018
Polymeric Micelles for Drug Delivery
RR WakaskarInternational Journal of Drug Development and Research 9 (3), 2, 2017201
27
2017
Types of Nanocarriers - Formulation Methods and Applications
RR WakaskarJournal of Bioequivalence and Bioavailability 9 (2), 10000e77, 2017201
22
2017
Challenges pertaining to adverse effects of drugs
RR WakaskarInternational Journal of Drug Development and Research 9 (3), 1-2, 2017201
21
2017
Cancer Therapy with Drug Delivery Systems
RR WakaskarJournal of Pharmacogenomics and Pharmacoproteomics 8 (1), 100e1578, 2017201
18
2017
Role of nanoparticles in drug delivery encompassing cancer therapeutics
RR WakaskarInternational Journal of Drug Development and Research 9 (3), 20120
7
2017
Utilization of nanoparticulate therapy in cancer targeting
E Narayanan, R WakaskarCogent Medicine 5 (1), 1504504, 2018201
6
2018
Sublingual opioid formulations containing naloxone
N Shan, RR Wakaskar, EA Baldwin, AB Schlinkert, M Wu, N YanUS Patent 10,265,309, 20195201
5
2019
Cancer Therapy with the Aid of Nanotherapeutics
RR WakaskarJournal of Biomolecular Research and Therapeutics 6 (2), 2, 2017201
4
2017
Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL (30)-PEG (5K) in primary murine syngeneic breast …
Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL (0)-PEG (5K) in primary murine syngeneic breast …VV Ambardekar, RR Wakaskar, Z Ye, SM Curran, TR McGuire, ...International journal of pharmaceutics 54 (1-2), 10-18, 2018201
3
2018
Polymeric Micelles and their Properties. J Nanomed Nanotechnol 8: 433. doi: 10.4172/2157-7439.1000433 Page 2 of 2 J Nanomed Nanotechnol, an open access journal ISSN: 2157-7439 …
Polymeric Micelles and their Properties. J Nanomed Nanotechnol 8: 433. doi: 10.417/157-7439.1000433 Page of J Nanomed Nanotechnol, an open access journal ISSN: 157-7439 …RR WakaskarCritical reviews in therapeutic drug carrier systems 6, 193-10, 01701
2
2017
A Phase 1, Single-Dose, Open-Label, 5-Treatment, Crossover, Pharmacokinetic Study of Comparative Bioavailability of Epinephrine Nasal Spray and EpiPen® in Healthy Adults With …
A Phase , Single-Dose, Open-Label, 5-Treatment, Crossover, Pharmacokinetic Study of Comparative Bioavailability of Epinephrine Nasal Spray and EpiPen® in Healthy Adults With …J Chen, S Chilampalli, G DeCastro, E Narayanan, RR Wakaskar, GJ AtieeJournal of Allergy and Clinical Immunology 43 (2), AB44, 20920
1
2019

Referred From: https://scholar.google.com/citations?user=UOZF5Y0AAAAJ&hl=en

Cited by
Citations 608
h-index 12
i10-index 12
Recommended Journals
Open Access Journals